Early Detection Research Network

Mitochondrial Genome Deletion for Detection of Prostate Cancer

Aliases:
This biomarker is also known as:
  • Mitochondrial Genome Deletion for Detection of Prostate Cancer,
  • Mitochondrial deletion for detection of prostate cancer,
  • Prostate Core Mitomic Test™,

Description…

The Prostate Core Mitomic Test™ is based upon a 3.4 kb mitochondrial genome deletion (3.4 mtdelta) that was identified through PCR analysis of frozen prostate cancer samples. In cancer research it has been found that deletions in mitochondrial DNA can correlate with cellular changes that indicate development of cancer. This deletion includes the terminal 22 bases of MT-ND4L, all of MT-ND4, 3 tRNAs (histidine, serine 2, and leucine 2), and all except the terminal 24 bases of MT-ND5.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
Type: Genomic
HGNC Name:

The following organs have data associated with this biomarker…

Attributes

Phase: Three
QA State: Curated
Organ-specific information for this biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.